Sananbenesi Farahnaz, Fischer Andre, Wang Xinyu, Schrick Christina, Neve Rachael, Radulovic Jelena, Tsai Li-Huei
Howard Hughes Medical Institute, Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Nat Neurosci. 2007 Aug;10(8):1012-9. doi: 10.1038/nn1943. Epub 2007 Jul 15.
Treatment of emotional disorders involves the promotion of extinction processes, which are defined as the learned reduction of fear. The molecular mechanisms underlying extinction have only begun to be elucidated. By employing genetic and pharmacological approaches in mice, we show here that extinction requires downregulation of Rac-1 and cyclin-dependent kinase 5 (Cdk5), and upregulation of p21 activated kinase-1 (PAK-1) activity. This is physiologically achieved by a Rac-1-dependent relocation of the Cdk5 activator p35 from the membrane to the cytosol and dissociation of p35 from PAK-1. Moreover, our data suggest that Cdk5/p35 activity prevents extinction in part by inhibition of PAK-1 activity in a Rac-1-dependent manner. We propose that extinction of contextual fear is regulated by counteracting components of a molecular pathway involving Rac-1, Cdk5 and PAK-1. Our data suggest that this pathway could provide a suitable target for therapeutic treatment of emotional disorders.
情绪障碍的治疗涉及促进消退过程,消退过程被定义为习得性恐惧的减轻。消退背后的分子机制才刚刚开始被阐明。通过在小鼠中采用基因和药理学方法,我们在此表明消退需要Rac-1和细胞周期蛋白依赖性激酶5(Cdk5)的下调以及p21激活激酶-1(PAK-1)活性的上调。这在生理上是通过Cdk5激活剂p35从膜向细胞质的Rac-1依赖性重新定位以及p35与PAK-1的解离来实现的。此外,我们的数据表明,Cdk5/p35活性部分通过以Rac-1依赖性方式抑制PAK-1活性来阻止消退。我们提出,情境性恐惧的消退是由涉及Rac-1、Cdk5和PAK-1的分子途径的拮抗成分调节的。我们的数据表明,该途径可能为情绪障碍的治疗提供合适的靶点。